Volume 5, Issue 3 (8-2020)
J Res Dent Maxillofac Sci 2020, 5(3): 33-36 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ara S, Fatima A. Acquired Immunity in Dentistry Students After Hepatitis B Vaccination. J Res Dent Maxillofac Sci 2020; 5 (3) :33-36
URL: http://jrdms.dentaliau.ac.ir/article-1-273-en.html
URL: http://jrdms.dentaliau.ac.ir/article-1-273-en.html
1- Professor, Department of oral medicine and radiology, Al Badar Rural Dental college and hospital, Kalaburagi
2- Post graduate student, Department of oral medicine and radiology, Al Badar Rural Dental college and hospital, Kalaburagi. ,fatima68645@yahoo.com
2- Post graduate student, Department of oral medicine and radiology, Al Badar Rural Dental college and hospital, Kalaburagi. ,
Abstract: (2610 Views)
Background and Aim: After triple-course vaccination against Hepatitis B (HB), there may be a failure to increase antibody titer value or to maintain it at satisfactory seroprotective levels. This study aimed to evaluate the rate of seroprotection in dental students after receiving complete doses of HB vaccination.
Materials and Methods: In this cross-sectional observational study, Anti-HBs levels of 100 dental students, who had received triple-course HB vaccines, were examined. Titres of more than 100 mIU/ml were considered as protective. The association between various parameters, like gender, age, duration of the last vaccination, booster dose, and comparison of anti-HBs levels at various durations from the last vaccination, was assessed.
Results: Of the 100 participants, 52 were females and 48 were males. The participants’ age ranged from 22 to 31 years with the mean age being 28.12±2.552 years in females and 26.88±3.512 years in males. Overall, 65% of the participants had a good immune response i.e. anti-HBs values were more than 100 mIU/ml, 24% had a moderate immune response i.e. anti-HBs values were 11-99 mIU/ml, and 11% had a poor immune response i.e. anti-HBs values were less than 10 mIU/ml.
Conclusion: There was a substantial failure rate in attaining or preserving satisfactory anti-HBs values after routine vaccinations against the HB virus (HBV). Hence, it is very important to determine post-vaccine serological anti-HBs values to take proper booster doses and maintain adequate immunity levels.
Materials and Methods: In this cross-sectional observational study, Anti-HBs levels of 100 dental students, who had received triple-course HB vaccines, were examined. Titres of more than 100 mIU/ml were considered as protective. The association between various parameters, like gender, age, duration of the last vaccination, booster dose, and comparison of anti-HBs levels at various durations from the last vaccination, was assessed.
Results: Of the 100 participants, 52 were females and 48 were males. The participants’ age ranged from 22 to 31 years with the mean age being 28.12±2.552 years in females and 26.88±3.512 years in males. Overall, 65% of the participants had a good immune response i.e. anti-HBs values were more than 100 mIU/ml, 24% had a moderate immune response i.e. anti-HBs values were 11-99 mIU/ml, and 11% had a poor immune response i.e. anti-HBs values were less than 10 mIU/ml.
Conclusion: There was a substantial failure rate in attaining or preserving satisfactory anti-HBs values after routine vaccinations against the HB virus (HBV). Hence, it is very important to determine post-vaccine serological anti-HBs values to take proper booster doses and maintain adequate immunity levels.
Type of Study: Original article |
Subject:
Oral medicine
References
1. Cohen FS. How Viruses Invade Cells. Biophys J. 2016 Mar 8; 110(5): 1028-32. [DOI:10.1016/j.bpj.2016.02.006] [PMID] [PMCID]
2. Krajden M, McNabb G, Petric. The Laboratory Diagnosis Of Hepatitis B Virus. Can J Infect Dis Med Microbiol. 2005 Mar-Apr; 16(2): 65-72. [DOI:10.1155/2005/450574] [PMID] [PMCID]
3. Moore MA, Macpherson LM, Kennedy C, Bagg J. Provision of hepatitis B vaccination for primary care dental staff in Scotland. J Infect. 2003 Nov;47(4):322-7. [DOI:10.1016/S0163-4453(03)00094-X]
4. Lindley MC, Lorick SA, Spinner JR, Krull AR, Mootrey GT, Ahmed F, Myers R, Bednash GP, Cymet TC, Maeshiro R, Raines CF, Shannon SC, Sondheimer HM, Strikas RA. Student vaccination requirements of U.S. health professional schools: a survey. Ann Intern Med. 2011 Mar 15;154(6):391-400. [DOI:10.7326/0003-4819-154-6-201103150-00004] [PMID]
5. Chaves SS, Fischer G, Groeger J, Patel PR, Thompson ND, Teshale EH, Stevenson K, Yano VM, Armstrong GL, Samandari T, Kamili S, Drobeniuc J, Hu DJ. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine.
6. Lasemi E, Haddadpour N, Navi F, Rakhshan A, Rakhshan V.Rate of acquired immunity in dental students after Hepatitis B Vaccination. Den Res J. 2011;8(3):128-31.
7. Rajabipour F. Evaluating Hbs Ab levels of interns studying in Lorestan University of Medical Sciences. Journal of Lorestan University of Medical Sciences (Sogand) 2002;5:1-5.
8. Ramezani A, Eslamifar A, Banifazl M, Ahmadi F, Maziar S, Razeghi E, Kalantar E, Amirkhani A, Aghakhani A. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients. Int J Clin Pract. 2009 Mar;63(3):394-7. [DOI:10.1111/j.1742-1241.2007.01470.x] [PMID]
9. Sivarajasingam V, Ogden GR. Hepatitis B vaccination: knowledge among clinical dental staff and students in Dundee. Br Dent J. 1995 Feb 11;178(3):105-7. [DOI:10.1038/sj.bdj.4808662] [PMID]
10. Estévez ZC, Betancourt AA, Muzio González V, Baile NF, Silva CV, Bernal FH, Arias EP, Delhanty Fernández A, Olazábal NM, del Río Martín A, Batista LL, Véliz Ríos G, Hernández HH, Hernández AB, Lugo EP, de la Torre Cruz J, Batista Marchec BL, Falcón LA, Brito JT, León DO, Saura PL. Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults. Biologicals. 2007 Apr;35(2):115-22. [DOI:10.1016/j.biologicals.2006.06.001] [PMID]
11. Velu V, Nandakumar S, Shanmugam S, Shankar EM, Thangavel S, Kulkarni PS, Thyagarajan SP. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India. Pediatr Infect Dis J. 2007 Nov;26(11):1038-41. [DOI:10.1097/INF.0b013e3181342887] [PMID]
12. Van Damme P, Minervini G, Liss CL, McCarson B, Vesikari T, Boslego JW, Bhuyan PK. Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults. Hum Vaccin. 2009 Feb;5(2):92-7. [DOI:10.4161/hv.5.2.6587] [PMID]
13. Schädler S, Hildt E. HBV life cycle: entry and morphogenesis. Viruses. 2009 Sep;1(2):185-209. [DOI:10.3390/v1020185] [PMID] [PMCID]
14. Sahana HV, Sarala N, Prasad SR. Decrease in Anti HBs Antibodies Over Time in Medical Students and Healthcare Workers After Hepatitis B Vaccination. BioMed Res Int. 2017;2017:1327492. [DOI:10.1155/2017/1327492] [PMID] [PMCID]
15. Rao TV, Suseela IJ, Sathiavathy KA. Estimation of antibodies to HBsAg in vaccinated health care workers. Indian J Med Microbiol. 2008;26(1):93-4. [DOI:10.4103/0255-0857.38876] [PMID]
16. Batra V, Goswami A, Dadhich S, Kothari D, Bhargava N. Hepatitis B immunization in healthcare workers. Ann Gastroenterol. 2015 Apr-Jun;28(2):276-80.
17. Tele SA, Martins RM, Lopes CL, dos Santos Carneiro MA, Souza KP, Yoshida CF. Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff. Eur J Epidemiol. 2001;17(2):145-9. [DOI:10.1023/A:1017918218784] [PMID]
18. Pamplona M, Margaix-Muñoz M, Sarrión-Pérez MG. Dental considerations in patients with liver diseases. J Clin Exp Dent. 2011;3(2):127-34. [DOI:10.4317/jced.3.e127]
19. Arias-Moliz MT, Rojas L, Liébana-Cabanillas F, Bernal C, Castillo F, Rodríguez-Archilla A, Castillo A, Liébana J. Serologic control against hepatitis B virus among dental students of the University of Granada, Spain. Med Oral Patol Oral Cir Bucal. 2015 Sep 1;20(5):e566-71. [DOI:10.4317/medoral.20579] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
